• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • DMF (Drug Master Filing) – Pharmaceutical Products
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • CML (China Manufacture Licence) – Pressure vessels
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Company Profile
    • Partners
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Information
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • DMF
      • CCC
      • Pressure Vessels
    • Publications
    • Brochure
    • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • China’s Regulatory Pathway for Customized Medical Devices (CMDs)

China’s Regulatory Pathway for Customized Medical Devices (CMDs)

Thursday, 12 March 2020 / Published in Medical Device

China’s Regulatory Pathway for Customized Medical Devices (CMDs)

On 04.07.2019, the China NMPA (National Medical Products Administration) and NHC (National Health Commission) jointly published the Notice (No.53-2019) in relation to the Provisions on the Supervision and Administration of Customized Medical Devices that became effective since 01.01.2020 to provide a regulatory pathway for CMDs to meet the special clinical demands for medical institutions to treat designated patients.

The provisions consist a total of 6 chapters and 35 articles to cover general principles, filing management, design and process, user management, supervision and administration, and supplementary provisions. The registration of CMDs must meet specific requirements including, but not limited to the following:

– A manufacturer and a medical institution are both required to be the filers of the customized medical device
– All CMDs must be originally manufactured and not outsourced to contractors
– Once the number of clinical cases and preliminary studies meet the requirements of pre-market approval, the registration of CMDs should be completed in accordance with the standard administrative measures for the registration of medical devices and IVDs.
– Submission of clinical data that are authentic, accurate, complete, and traceable, as well as meeting ethical standards will be considered as supporting materials during the registration application.

Tagged under: CMD, Customized Medical Devices, NMPA

What you can read next

NMPA UDI Database Officially Open to Public
NMPA Major Updates Concerning IVDs
Pilot Plan of the UDI System in Hainan Launched

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Drug Master Filing
      • Health Food
      • Medical Device
    • RoHS
  • Publications
  • Seminars
  • Webinars

Recent Posts

  • Updates on the Medical Device Classification Catalogue in China

    On December 31, 2020, the NMPA announced (No.14...
  • Cisema Partners with Advamed

    Cisema is delighted to announce it is now an as...
  • Guidelines for Sampling Testing on Organic Foods

    On December 4, 2020, the CNCA (Certification an...
  • Draft of Prohibited List and Existing List of Cosmetic Ingredients Announced

    On January 22, 2021, the NIFDC (China National ...
  • Guideline and Standard Update for Medical Devices & IVDs in January and February 2021

    China Regulatory Guidelines Issued / Updated Th...

Archive

Cisema

With nine locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Events
  • News & Information
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2019 Cisema. All rights reserved.

TOP